Veterinary Medicines

Equiparin 50.000 IU/100 g gel for horses

Authorised
  • Heparin sodium
  • Hydroxyethyl salicylate
  • Levomenthol
Download as PDF

Product identification

Medicine name:
Equiparin 50.000 IU/100 g gel for horses
Active substance:
  • Heparin sodium
  • Hydroxyethyl salicylate
  • Levomenthol
Target species:
  • Horse
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Heparin sodium
    50000.00
    international unit(s)
    /
    100.00
    gram(s)
  • Hydroxyethyl salicylate
    5.00
    gram(s)
    /
    100.00
    gram(s)
  • Levomenthol
    0.50
    gram(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Gel
Withdrawal period by route of administration:
  • Cutaneous use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM02AC99
Legal status of supply:
  • Medicinal product subject to special medical prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • (ID2): 1 unspecified outer container with 6 Bottle (PolyEthylene) with 190 gram(s) (1140 gram(s))
  • (ID1): 1 unspecified outer container with 1 Bottle (PolyEthylene) with 190 gram(s) (190 gram(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Animedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Animedica GmbH
Responsible authority:
  • VMD
Authorisation number:
  • VM 24745/4004
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0128/002
Concerned member states:
  • Austria
  • Hungary
  • Iceland
  • Ireland
  • Poland
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."